Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.32 USD | +3.65% | -6.95% | -25.03% |
09/05 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
08/05 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.03% | 1.11B | |
+18.52% | 47.02B | |
+48.77% | 41.86B | |
+0.43% | 41.76B | |
-4.27% | 28.8B | |
+11.77% | 26.05B | |
-22.06% | 19.15B | |
+4.56% | 12.55B | |
+29.84% | 12.34B | |
-4.04% | 11.82B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- JMP Securities Raises Pharvaris' Price Target to $49 From $40, Maintains Market Outperform Rating